Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

The Fluid Mosaic Model01:34

The Fluid Mosaic Model

147.5K
The fluid mosaic model was first proposed as a visual representation of research observations. The model comprises the composition and dynamics of membranes and serves as a foundation for future membrane-related studies. The model depicts the structure of the plasma membrane with a variety of components, which include phospholipids, proteins, and carbohydrates. These integral molecules are loosely bound, defining the cell’s border and providing fluidity for optimal function.
147.5K
Membrane Fluidity01:23

Membrane Fluidity

152.4K
Cell membranes are composed of phospholipids, proteins, and carbohydrates loosely attached to one another through chemical interactions. Molecules are generally able to move about in the plane of the membrane, giving the membrane its flexible nature called fluidity. Two other features of the membrane contribute to membrane fluidity: the chemical structure of the phospholipids and the presence of cholesterol in the membrane.
152.4K
Fluid Mosaic Model01:19

Fluid Mosaic Model

11.8K
Scientists identified the plasma membrane in the 1890s and its principal chemical components (lipids and proteins) by 1915. The model for plasma membrane structure, proposed in 1935 by Hugh Davson and James Danielli, was the first model to be widely accepted in the scientific community. The model was based on the plasma membrane's "railroad track" appearance in early electron micrographs. Davson and Danielli theorized that the plasma membrane's structure resembled a sandwich...
11.8K
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance01:07

Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance

40
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
40

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Unravelling the multi-scale structural organisation of in vivo ileal digesta from diets containing protein-seaweed polysaccharide blends.

Food research international (Ottawa, Ont.)·2026
Same author

Predictive Model of Dynamic Subphenotypes for 30-Day Mortality in Emergency Department Patients with Suspected Infection Using the Vital Signs of the First 24 Hours: An Analytical Cohort Study in a Tertiary Care Clinic.

Journal of clinical medicine·2026
Same author

Pharmacist-Led Interventions for Colorectal Cancer Prevention: A Systematic Review.

Current oncology (Toronto, Ont.)·2026
Same author

Molecular preselection of pediatric patients with solid tumors treated with tyrosine kinase inhibitors.

Future oncology (London, England)·2026
Same author

Quasi-randomized pilot clinical trial comparing the use of annexin columns in patients with abnormal sperm FISH undergoing IVF techniques.

Scientific reports·2025
Same author

Serum butyrylcholinesterase activity as a predictor of severity and mortality in COVID-19 patients.

Scientific reports·2025

相关实验视频

Updated: Jul 5, 2025

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.0K

奥塞尔塔米维尔酸盐与模型膜的相互作用

Adriána Čelková1, Alexander Búcsi1, Mária Klacsová1

  • 1Department of Physical Chemistry of Drugs, Faculty of Pharmacy, Comenius University Bratislava, Odbojárov10, 832 32 Bratislava, Slovakia.

Biochimica et biophysica acta. Biomembranes
|January 11, 2024
PubMed
概括

奥塞塔米维尔 (Tamiflu) 适度地影响脂质二层,改变膜性质,如侧面压力和表面电荷. 由于静电排斥,高度会破坏多层状结构.

关键词:
美国国家安全委员会 DSC.侧面压力侧面压力脂质膜是一种脂质膜.奥塞尔塔米维尔 (oseltamivir) 是一种分割系数的分配系数萨克斯 (SAXS) 的时间

更多相关视频

Detection of Neu1 Sialidase Activity in Regulating TOLL-like Receptor Activation
09:04

Detection of Neu1 Sialidase Activity in Regulating TOLL-like Receptor Activation

Published on: September 7, 2010

11.6K
Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
09:31

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals

Published on: April 15, 2017

17.9K

相关实验视频

Last Updated: Jul 5, 2025

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
08:31

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

5.0K
Detection of Neu1 Sialidase Activity in Regulating TOLL-like Receptor Activation
09:04

Detection of Neu1 Sialidase Activity in Regulating TOLL-like Receptor Activation

Published on: September 7, 2010

11.6K
Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
09:31

Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals

Published on: April 15, 2017

17.9K

科学领域:

  • 药理学 药理学是指药理学的学科.
  • 生物物理学的生物物理.
  • 材料科学 材料科学 材料科学

背景情况:

  • 作为流感的一种神经氨基酶抑制剂的奥塞尔塔米维尔在脂质水系统中缺乏详细的物理化学数据.
  • 了解药物膜相互作用对于预测药物行为和疗效至关重要.

研究的目的:

  • 为了研究奥塞尔塔米维尔与模型脂双层的相互作用.
  • 确定其对膜热力学,结构和性能的影响.

主要方法:

  • 实验确定的分区系数.
  • 极化光显微镜用于研究异性质性质.
  • 脂质双层的热和结构性质的分析.

主要成果:

  • 奥塞塔米维尔适度地影响脂质双层的疏水核,导致轻微的热和结构变化.
  • 它以度依赖的方式降低了双层乙烯链区域内的侧面压力.
  • 奥塞尔塔米维尔对双层表面产生正电荷,增加了泽塔潜力并改变了异构性质.
  • 高度的奥塞尔塔米维尔可通过静电排斥显著扰乱多叶膜结构.

结论:

  • 奥塞塔米维尔与脂双层相互作用,影响膜热力学和结构.
  • 药物的作用依赖于度,导致侧面压力和表面电荷的变化.
  • 在高度下发生显著的结构破坏,突出显示了静电相互作用的重要性.